Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Hawkinson Russ, Président. Director active across 1 company, notably Silverback Therapeutics, Inc.. Cumulatively, 3 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €3k. Activity tracked since 1 February 2022. The latest transaction was filed on 2 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Russ Hawkinson is the President of Silverback Therapeutics, Inc. He oversees the company's operations in the biotechnology field. His leadership is crucial for the ongoing innovation and growth of Silverback Therapeutics.